Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AlfaCare Danmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   33.0% 14.3% 15.9% 12.2% 9.9% 11.7% 16.2% 16.0%   Credit score (0-100)   1 15 11 19 24 21 11 12   Credit rating   C BB BB BB BB BB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -384 732 306 321 534 311 0.0 0.0   EBITDA   -856 526 182 224 534 311 0.0 0.0   EBIT   -861 526 182 224 534 311 0.0 0.0   Pre-tax profit (PTP)   -861.2 530.8 130.4 188.9 524.5 282.4 0.0 0.0   Net earnings   -861.2 530.8 130.4 188.9 524.5 282.4 0.0 0.0   Pre-tax profit without non-rec. items   -861 531 130 189 524 282 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -1,761 -1,230 -1,100 -911 -387 -104 -154 -154   Interest-bearing liabilities   1,378 1,305 1,307 1,461 545 346 154 154   Balance sheet total (assets)   364 732 664 1,314 802 489 0.0 0.0   Net Debt   1,337 909 1,115 1,406 427 173 154 154     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -384 732 306 321 534 311 0.0 0.0   Gross profit growth   0.0% 0.0% -58.3% 5.0% 66.5% -41.7% -100.0% 0.0%   Employees   2 1 1 1 0 0 0 0   Employee growth %   0.0% -50.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   364 732 664 1,314 802 489 0 0   Balance sheet change%   -77.7% 101.1% -9.2% 97.8% -38.9% -39.1% -100.0% 0.0%   Added value   -855.5 526.1 182.5 224.1 534.4 311.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -10 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   224.1% 71.9% 59.7% 69.8% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -36.9% 26.2% 9.9% 11.3% 31.9% 38.9% 0.0% 0.0%   ROI %   -46.6% 39.9% 14.1% 16.3% 54.2% 77.7% 0.0% 0.0%   ROE %   -86.2% 96.8% 18.7% 19.1% 49.6% 43.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -82.9% -62.7% -62.3% -40.9% -32.5% -17.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -156.3% 172.7% 610.8% 627.4% 79.9% 55.7% 0.0% 0.0%   Gearing %   -78.2% -106.1% -118.8% -160.4% -140.8% -331.9% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.4% 4.1% 2.7% 2.0% 14.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.1 0.6 0.6 0.5 0.7 0.9 0.0 0.0   Current Ratio   0.2 0.7 0.6 0.8 0.7 0.9 0.0 0.0   Cash and cash equivalent   41.1 396.6 192.1 55.9 117.6 172.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,762.0 -308.8 -370.8 -435.8 -333.1 -49.1 -77.2 -77.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -428 526 182 224 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -428 526 182 224 0 0 0 0   EBIT / employee   -430 526 182 224 0 0 0 0   Net earnings / employee   -431 531 130 189 0 0 0 0